文献速递神经肿瘤神经重症

大型动物模型中慢性对流增强递送拓扑替康的植入式泵输注系统验证

Validation of an effective implantable pump-infusion system for chronic convection-enhanced delivery of intracerebral topotecan in a large animal model.
PubMed 文献 · J Neurosurg · 2019-08-02

该研究在12头猪中植入全内化对流增强递送(CED)泵导管系统,评估长期输注拓扑替康(TPT)与钆混合物的安全性和分布。结果显示所有动物耐受良好,平均神经行为评分8.99,平均最大分布体积(Vdmax)为11.30 mL,占同侧大脑半球体积的32.73%,且钆信号与组织TPT浓度相关(p=0.0078)。结论认为经内化系统长期TPT-钆CED安全耐受,可达到较大Vdmax并维持稳定分布长达32天。

要点

  • 全内化泵导管系统可安全进行长达32天的慢性CED输注。
  • 钆可作为MRI替代标志物评估TPT分布,与组织浓度相关。
  • 延长CED可能成为特定患者的安全治疗选择。

核心结论

  • 经内化系统长期输注TPT-钆安全且耐受良好,可达到较大Vdmax并维持稳定Vd长达32天。
  • 钆信号可作为测量药物分布的可识别替代标志物。
  • 延长CED可能是特定患者广泛适用且安全的治疗选择。

研究设计与样本

  • 在12头猪中植入全内化CED泵导管系统。
  • 输注方案包括可变输注计划、流速和TPT与钆混合物的浓度,输注间隔从4天至32天递增。
  • 通过MRI钆信号作为替代测量治疗分布,并使用9点神经行为量表(NBS)识别副作用。

主要发现

  • 所有动物均耐受输注,无严重不良事件。
  • 平均NBS评分为8.99。
  • 慢性输注动物的平均最大分布体积(Vdmax)为11.30 mL,占同侧大脑半球体积的32.73%。
  • Vdmax在输注早期即达到,尽管在输注达到稳态时略有下降,但保持相对稳定。
  • 液相色谱质谱法测量的新型组织TPT浓度与MRI钆信号强度相关(p = 0.0078)。

临床怎么用

  • 全内化泵导管系统可用于慢性CED输注,避免外置导管相关限制。
  • 钆共输注可用于MRI监测药物分布。
  • 长期TPT CED可能作为特定患者的安全治疗选项。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Intracerebral convection-enhanced delivery (CED) has been limited to short durations due to a reliance on externalized catheters. Preclinical studies investigating topotecan (TPT) CED for glioma have suggested that prolonged infusion improves survival. Internalized pump-catheter systems may facilitate chronic infusion. The authors describe the safety and utility of long-term TPT CED in a porcine model and correlation of drug distribution through coinfusion of gadolinium. METHODS: Fully internalized CED pump-catheter systems were implanted in 12 pigs. Infusion algorithms featuring variable infusion schedules, flow rates, and concentrations of a mixture of TPT and gadolinium were characterized over increasing intervals from 4 to 32 days. Therapy distribution was measured using gadolinium signal on MRI as a surrogate. A 9-point neurobehavioral scale (NBS) was used to identify side effects. RESULTS: All animals tolerated infusion without serious adverse events. The average NBS score was 8.99. The average maximum volume of distribution (Vdmax) in chronically infused animals was 11.30 mL and represented 32.73% of the ipsilateral cerebral hemispheric volume. Vdmax was achieved early during infusions and remained relatively stable despite a slight decline as the infusion reached steady state. Novel tissue TPT concentrations measured by liquid chromatography mass spectroscopy correlated with gadolinium signal intensity on MRI (p = 0.0078). CONCLUSIONS: Prolonged TPT-gadolinium CED via an internalized system is safe and well tolerated and can achieve a large Vdmax, as well as maintain a stable Vd for up to 32 days. Gadolinium provides an identifiable surrogate for measuring drug distribution. Extended CED is potentially a broadly applicable and safe therapeutic option in select patients.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. D'Amico RS, Neira JA, Yun J, et al. Validation of an effective implantable pump-infusion system for chronic convection-enhanced delivery of intracerebral topotecan in a large animal model. J Neurosurg. 2019. PMID: 31374547. doi:10.3171/2019.3.JNS1963

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。